Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1686

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1686
---
The purpose of the 2022 Plan is to attract and
retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors
and consultants, and to promote the success of our business. The administrator of the 2022 Plan may, in its sole discretion, amend, alter,
suspend or terminate the 2022 Plan, or any part thereof, at any time and for any reason. We will obtain stockholder approval of any 2022
Plan amendment to the extent necessary and desirable to comply with legal and regulatory requirements relating to the administration
of equity-based awards. Unless earlier terminated by the administrator, the 2022 Plan will terminate ten years from the date it is adopted
by our Board.

70

Plan Administration

One or more committees appointed by our Board
will administer the 2022 Plan. Initially, the Compensation Committee shall administer the 2022 Plan. In addition, if we determine it
is desirable to qualify transactions under the 2022 Plan as exempt under Rule 16b-3 of the Exchange Act, such transactions will be structured
with the intent that they satisfy the requirements for exemption under Rule 16b-3. Subject to the provisions of the 2022 Plan, the administrator
has the power to administer the 2022 Plan and make all determinations deemed necessary or advisable for administering the 2022 Plan,
including the power to determine the fair market value of our common stock, select the service providers to whom awards may be granted,
determine the number of shares covered by each award, approve forms of award agreements for use under the 2022 Plan, determine the terms
and conditions of awards (including the exercise price, the time or times at which the awards may be exercised, any vesting acceleration
or waiver or forfeiture restrictions and any restriction or limitation regarding any award or the shares relating thereto), construe
and interpret the terms of the 2022 Plan and awards granted under it, prescribe, amend and rescind rules relating to the 2022 Plan, rules
and regulations relating to sub-plans established for the purpose of facilitating compliance with applicable non-U.S. laws, easing the
administration of the 2022 Plan and/or for qualifying for favorable tax treatment under applicable non-U.S. laws, in each case as the
administrator may deem necessary or advisable and modify or amend each award (subject to the provisions of the 2022 Plan), including
the discretionary authority to extend the post-termination exercisability